PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
First Trust Amex Biotechnology Index (FBT)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

ETF Info

ISINUS33733E2037
CUSIP33733E203
IssuerFirst Trust
Inception DateJun 23, 2006
RegionNorth America (U.S.)
CategoryHealth & Biotech Equities
Index TrackedNYSE Arca Biotechnology Index
Home Pagewww.ftportfolios.com
Asset ClassEquity

Asset Class Size

Multi-Cap

Asset Class Style

Growth

Expense Ratio

The First Trust Amex Biotechnology Index has a high expense ratio of 0.57%, indicating higher-than-average management fees.


Expense ratio chart for FBT: current value at 0.57% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.57%

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


First Trust Amex Biotechnology Index

Popular comparisons: FBT vs. XBI, FBT vs. BBH, FBT vs. FXH, FBT vs. BBP, FBT vs. QQQ, FBT vs. HELX, FBT vs. XLV, FBT vs. fdn, FBT vs. FIW, FBT vs. IBB

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in First Trust Amex Biotechnology Index, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%5.00%10.00%15.00%20.00%25.00%NovemberDecember2024FebruaryMarchApril
4.28%
18.82%
FBT (First Trust Amex Biotechnology Index)
Benchmark (^GSPC)

S&P 500

Returns By Period

First Trust Amex Biotechnology Index had a return of -9.57% year-to-date (YTD) and -9.50% in the last 12 months. Over the past 10 years, First Trust Amex Biotechnology Index had an annualized return of 7.33%, while the S&P 500 had an annualized return of 10.42%, indicating that First Trust Amex Biotechnology Index did not perform as well as the benchmark.


PeriodReturnBenchmark
Year-To-Date-9.57%5.05%
1 month-6.69%-4.27%
6 months4.28%18.82%
1 year-9.50%21.22%
5 years (annualized)0.92%11.38%
10 years (annualized)7.33%10.42%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2024-5.78%1.22%2.01%
2023-5.31%-9.15%6.27%11.87%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of FBT is 6, indicating that it is in the bottom 6% of the market in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.

The Risk-Adjusted Performance Rank of FBT is 66
First Trust Amex Biotechnology Index(FBT)
The Sharpe Ratio Rank of FBT is 77Sharpe Ratio Rank
The Sortino Ratio Rank of FBT is 77Sortino Ratio Rank
The Omega Ratio Rank of FBT is 77Omega Ratio Rank
The Calmar Ratio Rank of FBT is 55Calmar Ratio Rank
The Martin Ratio Rank of FBT is 33Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for First Trust Amex Biotechnology Index (FBT) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


FBT
Sharpe ratio
The chart of Sharpe ratio for FBT, currently valued at -0.48, compared to the broader market-1.000.001.002.003.004.00-0.48
Sortino ratio
The chart of Sortino ratio for FBT, currently valued at -0.57, compared to the broader market-2.000.002.004.006.008.00-0.57
Omega ratio
The chart of Omega ratio for FBT, currently valued at 0.93, compared to the broader market1.001.502.000.93
Calmar ratio
The chart of Calmar ratio for FBT, currently valued at -0.31, compared to the broader market0.002.004.006.008.0010.00-0.31
Martin ratio
The chart of Martin ratio for FBT, currently valued at -1.21, compared to the broader market0.0010.0020.0030.0040.0050.00-1.21
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 1.81, compared to the broader market-1.000.001.002.003.004.001.81
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.64, compared to the broader market-2.000.002.004.006.008.002.64
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.31, compared to the broader market1.001.502.001.32
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.38, compared to the broader market0.002.004.006.008.0010.001.38
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 7.21, compared to the broader market0.0010.0020.0030.0040.0050.007.21

Sharpe Ratio

The current First Trust Amex Biotechnology Index Sharpe ratio is -0.48. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00NovemberDecember2024FebruaryMarchApril
-0.48
1.81
FBT (First Trust Amex Biotechnology Index)
Benchmark (^GSPC)

Dividends

Dividend History

First Trust Amex Biotechnology Index granted a 0.00% dividend yield in the last twelve months. The annual payout for that period amounted to $0.00 per share.


PeriodTTM2023202220212020201920182017201620152014
Dividend$0.00$0.00$0.00$2.21$0.00$0.00$0.00$0.00$0.00$0.13$0.05

Dividend yield

0.00%0.00%0.00%1.37%0.00%0.00%0.00%0.00%0.00%0.12%0.05%

Monthly Dividends

The table displays the monthly dividend distributions for First Trust Amex Biotechnology Index. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDec
2024$0.00$0.00$0.00
2023$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2022$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2021$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$2.21
2020$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2019$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2018$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2017$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2016$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2015$0.00$0.00$0.05$0.00$0.00$0.06$0.00$0.00$0.02$0.00$0.00$0.00
2014$0.05

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-25.00%-20.00%-15.00%-10.00%-5.00%0.00%NovemberDecember2024FebruaryMarchApril
-21.61%
-4.64%
FBT (First Trust Amex Biotechnology Index)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the First Trust Amex Biotechnology Index. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the First Trust Amex Biotechnology Index was 40.51%, occurring on Feb 11, 2016. Recovery took 484 trading sessions.

The current First Trust Amex Biotechnology Index drawdown is 21.61%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-40.51%Jul 20, 2015144Feb 11, 2016484Jan 12, 2018628
-39.83%Aug 15, 200870Nov 21, 2008174Aug 4, 2009244
-34.04%Apr 29, 2011147Nov 25, 2011161Jul 18, 2012308
-32.37%Feb 9, 2021340Jun 14, 2022
-28.05%Sep 28, 201860Dec 24, 2018346May 11, 2020406

Volatility

Volatility Chart

The current First Trust Amex Biotechnology Index volatility is 4.39%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%7.00%8.00%NovemberDecember2024FebruaryMarchApril
4.39%
3.30%
FBT (First Trust Amex Biotechnology Index)
Benchmark (^GSPC)